Regulation and AI Governance

Ex-Google Duplex Eng Lead on Disrupting $2B Clinical Trials with AI - Patrick Leung

Topic 9 of 18

Published Jul 28, 2025 · Clip 21:28–23:29 (2:02)

Patrick argues regulatory bodies evaluate output quality, so if AI-generated protocols are as good as human ones, regulators will be fine. Faro mitigates risks by running models in private environments where data isn't shared, and as an enterprise-only tool. The company maintains an AI governance policy, plans to publish it to raise industry standards, noting customers are even more concerned than the FDA because it's their intellectual property.